Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jumpei Takeshita
Observed names:
J. Takeshita,
JUMPEI TAKESHITA,
Takeshita, Jumpei
Institutions:
Kansai Electric Power (Japan),
Kansai Electric Power Hospital
Observed institutions:
Kansai Electric Power (Japan),
Kansai Electric Power Hospital,
Kobe City Medical Center General Hospital,
Foundation for Biomedical Research and Innovation,
The University of Tokyo
OpenAlex ID:
A5090494204
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
2018
·
Julija Hmeljak
, Francisco Sanchez-Vega
, et al.
·
Cancer Discovery
·
675
Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor: Comparison between T790M mutation‐positive and mutation‐negative populations
2013
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Cancer
·
186
CT-Guided Fine-Needle Aspiration and Core Needle Biopsies of Pulmonary Lesions: A Single-Center Experience With 750 Biopsies in Japan
2014
·
Jumpei Takeshita
, Katsuhiro Masago
, et al.
·
American Journal of Roentgenology
·
133
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
2015
·
Takahisa Kawamura
, Akito Hata
, et al.
·
Cancer Chemotherapy and Pharmacology
·
79
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation
2013
·
Kosuke Tanaka
, Akito Hata
, et al.
·
Journal of Thoracic Oncology
·
47
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
2015
·
Kyoko Otsuka
, Akito Hata
, et al.
·
Cancer Chemotherapy and Pharmacology
·
44
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer
2014
·
KATSUHIRO MASAGO
, DAICHI FUJIMOTO
, et al.
·
Molecular and Clinical Oncology
·
39
PDF
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations
2015
·
Katsuhiro Masago
, Shiro Fujita
, et al.
·
BMC Cancer
·
33
PDF
Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.
2015
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
PubMed
·
29
Prognostic Value of Bronchoalveolar Lavage in Patients with Non-HIV Pneumocystis Pneumonia
2014
·
Koji Tamai
, Ryo Tachikawa
, et al.
·
Internal Medicine
·
22
PDF
Multiple Primary Malignancies in Patients with Non-Small Cell Lung Cancer
2015
·
Shiro Fujita
, Katsuhiro Masago
, et al.
·
Internal Medicine
·
19
PDF
PITX1 inhibits the growth and proliferation of melanoma cells through regulation of SOX family genes
2021
·
Takahito Ohira
, Suguru Nakagawa
, et al.
·
Scientific Reports
·
17
PDF
Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR -mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer
2015
·
Akihiro Nishiyama
, Nobuyuki Katakami
, et al.
·
Lung Cancer
·
14
Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer
2015
·
Shiro Fujita
, Katsuhiro Masago
, et al.
·
PLoS ONE
·
10
PDF
Rebiopsy of non-small cell lung cancer patients with acquired resistance to EGFR-TKI: Comparison between T790M mutation-positive and -negative populations.
2012
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Journal of Clinical Oncology
·
10
A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy.
2015
·
Jumpei Takeshita
, Katsuhiro Masago
, et al.
·
PubMed
·
8
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
2015
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
Cancer Chemotherapy and Pharmacology
·
8
Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment
2014
·
Kentaro Iwata
, Asako Doi
, et al.
·
International Journal of General Medicine
·
8
PDF
Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancer.
2014
·
Akito Hata
, Nobuyuki Katakami
, et al.
·
PubMed
·
6
Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients
2014
·
JUMPEI TAKESHITA
, KATSUHIRO MASAGO
, et al.
·
Molecular and Clinical Oncology
·
4
PDF
High-dose erlotinib for refractory leptomeningeal metastases (LM) after failure of standard dose EGFR-TKIs.
2013
·
Takahisa Kawamura
, Akito Hata
, et al.
·
Journal of Clinical Oncology
·
3
Early diagnosis and bevacizumab combined with chemotherapy improved pulmonary tumor thrombotic microangiopathy with lung adenocarcinoma: A case report
2022
·
Takeshi Kotake
, Yasuki Adachi
, et al.
·
Current Problems in Cancer Case Reports
·
2
PDF
Pleural Metastases from Papillary Thyroid Carcinoma Mimicking Mesothelioma
2014
·
Jumpei Takeshita
, Nobuyuki Katakami
, et al.
·
Internal Medicine
·
1
PDF
Retrospective Efficacy and Safety Analysis of Erlotinib (E), Pemetrexed (P) and Docetaxel (D) in Previously Treated Non-Small-Cell Lung Cancer Patients (NSCLC) without EGFR Mutation
2012
·
J. Takeshita
, N. Katakami
, et al.
·
Annals of Oncology
·
1
PDF
Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma
2023
·
Julija Hmeljak
, Francisco Sanchez-Vega
, et al.
Show more works
View as search
Works count:
40
Citation count:
1,397
H-index:
13
I10-index:
15
Year
Topic
Type